Moreover, the USP28 substrate STAT3 participates in the drug resistance of cancer therapy, suggesting that USP28 may play an essential role in therapy resistance in non-small cell lung cancer [33, 124] (Table 2). This evidence concerns the gene STAT3 and non-small cell lung carcinoma.